Clinical Trial Update: The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study [Phase 2]

View source ↗

Summary

This update reports that the Phase II TSUBAKI study of bardoxolone methyl in patients with chronic kidney disease and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | Status: COMPLETED